A Study of RC48-ADC in Local Advanced or Metastatic Gastric Cancer Subjects With the Overexpression of HER2
Clinical trial NCT03556345 · COMPLETED
Trial details
- NCT number
- NCT03556345
- Sponsor
- RemeGen Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-07-10
- Primary completion
- 2020-06-01
- Enrollment
- 127
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.